Psilocybin in British Columbia and Vancouver: what the law says, what research exists, and who can legally access it

Is psilocybin legal in British Columbia, and can anyone in Vancouver legally get it? As of 14 October 2026, the short version is that British Columbia has no separate regime for psilocybin. The rules are federal, they are the same in Vancouver as in Victoria or Prince George, and what varies by place is mainly where clinical trials are running. Health Canada says that the production, sale and possession of magic mushrooms are illegal in Canada and that no therapeutic product containing psilocybin is approved.

This article sets out what we could confirm from primary and official pages: Health Canada, the federal statute, the Government of British Columbia and the ClinicalTrials.gov registry. It also says what we looked for and could not confirm. It does not recommend any clinic, retailer, provider or product, and it is not a way to obtain psilocybin.

What federal law applies in British Columbia?

Criminal drug law is federal, so the same statute governs the whole province. Psilocybin is listed in Schedule III of the Controlled Drugs and Substances Act (the version we read was current to 21 September 2026). Health Canada states that possession, sale and production are prohibited unless it authorizes the activity, for example through a licence, an exemption or a regulation (Health Canada).

The same Health Canada page describes the three ways it says psilocybin may legally reach people for medical reasons, each needing a regulated health care practitioner: clinical trials, the Special Access Program and individual subsection 56(1) exemptions (Health Canada). We do not repeat the detail here. It is covered in our Ontario guide, in are magic mushrooms legal in Canada?, and in the explainers on the Special Access Program and section 56 exemptions.

Did BC’s decriminalization exemption cover psilocybin?

No, on the documents we read. The Government of British Columbia’s news release of 31 May 2022 announced that Health Canada had granted a subsection 56(1) exemption for the province, running from 31 January 2023 to 31 January 2026, under which adults with 2.5 grams or less for personal use would not be arrested, charged or have their drugs seized. The release refers only to “certain illicit substances” and does not name them.

Health Canada’s fact sheet on the exemption does name them. It defines the covered substances as an opioid, cocaine, methamphetamine or MDMA, with a combined maximum of 2.5 grams per adult, and states that the version in effect from 7 May 2024 applied in designated health care clinics, to unhoused adults sheltering in accordance with applicable laws, and within private residences. The page does not mention psilocybin or magic mushrooms. Psilocybin was therefore not a listed substance in that exemption.

The exemption has ended. The BC government’s decriminalization page (updated 29 May 2026) says that the exemption expired on 31 January 2026 and will not be renewed, and the Health Canada fact sheet is marked as expired. We found no replacement exemption on the pages we opened. That means that, today, no provincial arrangement exists in BC that treats personal possession of any controlled drug differently from the rest of Canada, and psilocybin was never part of it.

This is worth stating because the BC policy is often described loosely as “decriminalizing drugs”. Even while it was in force it was a time-limited, substance-specific federal exemption, not a change to the statute, and it was not legalization (Health Canada fact sheet). What happens to a person found with an illegal substance, and how police and prosecutors use discretion, are questions for a lawyer; for the general position on penalties see our guide to penalties in Canada.

What has the City of Vancouver done about psilocybin?

A city cannot legalize a federally controlled drug, and we found nothing showing that the City of Vancouver has. What the record we could open does show is a local argument about unlicensed storefronts that sell it. We could not open the City’s own council documents (the servers refused our requests), so this section rests on a political party’s account of a motion and on a news report of a licence hearing, and it should be read with that limit in mind.

According to the Green Party of Vancouver, councillors Pete Fry and Adriane Carr put forward a motion, scheduled for the council meeting of 10 April 2024, asking city staff to report back on a regulatory framework for retail sales of psilocybin and entheogens, modelled on the city’s 2015 approach to cannabis retail. We did not verify what council decided from the official record, and we therefore do not state an outcome.

A Daily Hive report describes an earlier episode: on 5 March 2024, a council hearing voted to end the suspension of a business licence that the chief licence inspector had imposed in May 2023 on a dispensary, on the ground that the shop had misrepresented what it sold. The report says the licence had been issued for gifts and novelties. A business licence is a municipal permit to operate a business; it is not an authorization under the Controlled Drugs and Substances Act, and nothing in the report says otherwise. We name no shop and give no location.

Two things are not documented in what we could open. We found no City of Vancouver council motion asking Health Canada for a psilocybin-specific exemption, and we found no pilot or exemption in Vancouver or elsewhere in BC that authorizes public access to psilocybin outside the federal routes. The City’s own pages may say more than we could reach, so a reader who needs the current position should check the City’s council records directly.

Which psilocybin clinical trials list a British Columbia site?

This is where most of what exists sits. We queried the ClinicalTrials.gov API (version 2.0.5, data timestamp 14 October 2026) for studies with psilocybin as an intervention and a British Columbia location, then checked the broader place searches “Vancouver”, “Kelowna” and “BC” and read each candidate record. Studies in other places with the same city name (for example Vancouver, Washington) were excluded. The table shows the 8 studies whose records list a British Columbia site, as the registry showed them on 14 October 2026.

One caution about completeness: the registry’s location fields are free text and are not always consistent, so a study whose BC site is entered in an unusual way may not appear in a search. The first search on the exact province name returned only 3 of these 8. We treat the table as a snapshot of what we found, not a count of every study in the province.

What does the registry list tell you, and what does it not?

It shows that psilocybin research touches several parts of BC, with sites in the Lower Mainland, the Okanagan and the Interior, and that the lead sponsors are a mix of a university, individual investigators and companies. Of the 8, 3 were recruiting overall, 1 had not yet started recruiting, 1 was active but not recruiting, 2 had an unknown status and 1 was withdrawn. Withdrawn means the study was stopped before enrolling anyone.

It does not show that anyone can walk in, that a study will accept a given person, or that the intervention works. Each protocol sets its own eligibility, and registry entries can lag the real situation: two studies carry an unknown status. For one of the 8 (NCT05711940) the registry gives no province for its two Vancouver site entries, although the same record lists Kamloops, Kelowna and Penticton in British Columbia, so we included it. Health Canada’s page advises people interested in a trial to talk to their health care provider. We do not list contact routes for any study.

How can a person in BC legally get psilocybin today?

Only through the federal routes, and none of them is a service a person can simply request. The first is a clinical trial that Health Canada has authorized and a research ethics board has approved; Health Canada calls trials the most appropriate and effective way to advance research with psilocybin and the first legal route to pursue (Health Canada). The BC trials in the table above are examples of that route.

The second is the Special Access Program. Health Canada’s program page describes it as a route for health and dental practitioners to request a drug that is unavailable for sale in Canada, for a serious or life-threatening condition where conventional treatments have failed, are unsuitable or are unavailable. The practitioner must be entitled to practise and prescribe in their province. The page does not describe patients applying themselves, and Health Canada’s psilocybin page says that a request for psilocybin is not guaranteed to be granted.

The third is an individual subsection 56(1) exemption, a discretionary power of the Minister of Health to exempt a person or substance for scientific, medical or public interest purposes. Health Canada says the trial and SAP pathways should generally be pursued instead, and that a request needs a supporting letter from a medical practitioner (Health Canada). We found no published count of how many such authorizations exist for people in BC and we do not claim one.

For context on the wider picture in Canada, including the evidence behind the trials, see our guide to psilocybin-assisted therapy in Canada and the depression trials.

What is not legally available in British Columbia?

Anything outside those routes. Health Canada says activities with magic mushrooms are illegal unless authorized by Health Canada (Health Canada). A municipal business licence, a storefront, a website or an unlicensed “compassion” label does not change that. An unauthorized service sits outside the safeguards of a trial or an SAP authorization, and nothing about its product has been assessed by Health Canada. See are magic mushrooms safe?.

This article is general information about the law and the research. It is not a guide to obtaining psilocybin, and a trial listing is not a recommendation of any study, clinic or provider.

What can this article not tell you?

• How the City of Vancouver’s council voted on psilocybin motions. We could not open the council records and do not state outcomes we did not verify.
• How Health Canada’s guidance on the access routes reads under the federal Controlled Substances Regulations that came into force on 1 October 2026. Its psilocybin page was updated on 20 October 2026, and the one wording change we found is in its clinical-trials section, which now names those Regulations as the authorization needed to sell psilocybin for clinical testing (the earlier version named Part J of the Food and Drug Regulations). The page does not otherwise discuss them (Health Canada).
• How often the Special Access Program and individual exemptions are granted for psilocybin in BC. We found no official figures.
• Whether a given trial is open to a given person. Registry status is not an eligibility statement.
• How police or courts will treat any particular situation. That is a question for a lawyer.
• Whether BC will adopt any new exemption or pilot after 31 January 2026 (Government of British Columbia). We found no announcement.

How can you check the current position?

Read Health Canada’s psilocybin page and its Special Access Program page, and the BC government’s decriminalization page for any announcement of a new exemption. Search ClinicalTrials.gov for psilocybin and your province, which is the same query we used. Then ask a regulated health care practitioner about your own situation, and a Canadian lawyer for a legal question. If you or someone near you is in crisis, call or text 9-8-8 or call 911, and see our safety page for further resources.

Shroomverse sells mushroom products. This article is general information about the law and clinical research. It is not medical or legal advice, and it does not recommend any product, provider or clinic.